Hans Persson

9.0k total citations · 1 hit paper
155 papers, 6.0k citations indexed

About

Hans Persson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Hans Persson has authored 155 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 32 papers in Molecular Biology and 17 papers in Cognitive Neuroscience. Recurrent topics in Hans Persson's work include Heart Failure Treatment and Management (51 papers), Cardiovascular Function and Risk Factors (42 papers) and Retinal Development and Disorders (24 papers). Hans Persson is often cited by papers focused on Heart Failure Treatment and Management (51 papers), Cardiovascular Function and Risk Factors (42 papers) and Retinal Development and Disorders (24 papers). Hans Persson collaborates with scholars based in Sweden, United Kingdom and France. Hans Persson's co-authors include Peter Wanger, Gunilla Sjöberg, John A. Haines, Jenny Pronczuk de Garbino, Bengt Knave, Christine Karlson-Stiber, Ulf Dahlström, Märit Mejhert, Magnus Edner and Robert S. McKelvie and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Hans Persson

152 papers receiving 5.7k citations

Hit Papers

Poisoning Severity Score.... 1998 2026 2007 2016 1998 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hans Persson 2.8k 938 729 594 507 155 6.0k
Philippe Lechat 3.7k 1.3× 806 0.9× 224 0.3× 494 0.8× 413 0.8× 168 7.3k
John E. Smialek 2.3k 0.8× 887 0.9× 910 1.2× 1.0k 1.7× 1.4k 2.8× 145 7.8k
Udo Reulbach 649 0.2× 662 0.7× 182 0.2× 201 0.3× 477 0.9× 134 4.7k
Emanuela Turillazzi 697 0.3× 1.1k 1.2× 351 0.5× 231 0.4× 371 0.7× 186 4.6k
Eike Martin 1.0k 0.4× 917 1.0× 925 1.3× 753 1.3× 177 0.3× 147 7.0k
Jing Tian 1.3k 0.5× 556 0.6× 141 0.2× 297 0.5× 758 1.5× 152 5.3k
Cristoforo Pomara 525 0.2× 987 1.1× 283 0.4× 274 0.5× 424 0.8× 143 3.9k
Deborah Gustafson 603 0.2× 1.1k 1.1× 840 1.2× 314 0.5× 232 0.5× 235 8.8k
Jackie F. Price 1.9k 0.7× 1.1k 1.1× 143 0.2× 2.0k 3.3× 346 0.7× 185 10.4k
Patrick M. Sluss 1.4k 0.5× 2.4k 2.6× 231 0.3× 702 1.2× 270 0.5× 163 11.3k

Countries citing papers authored by Hans Persson

Since Specialization
Citations

This map shows the geographic impact of Hans Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Persson more than expected).

Fields of papers citing papers by Hans Persson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Persson. The network helps show where Hans Persson may publish in the future.

Co-authorship network of co-authors of Hans Persson

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Persson. A scholar is included among the top collaborators of Hans Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Persson. Hans Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donal, Erwan, Camilla Hage, Emmanuel Oger, et al.. (2024). Rates and Predictors of Cardiovascular and Non-Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 11(6). 3572–3583. 2 indexed citations
2.
Ekström, Mattias, Maria J. Eriksson, Matthias Corbascio, et al.. (2024). Characteristics of gene expression in epicardial adipose tissue and subcutaneous adipose tissue in patients at risk for heart failure undergoing coronary artery bypass grafting. BMC Genomics. 25(1). 938–938. 1 indexed citations
3.
4.
Eriksson, Maria J., Anna Walentinsson, Matthias Corbascio, et al.. (2019). Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction. Scientific Reports. 9(1). 3179–3179. 39 indexed citations
5.
Schaufelberger, Maria, et al.. (2019). Validity of Heart Failure Diagnoses Made in 2000–2012 in Western Sweden. ESC Heart Failure. 7(1). 37–46. 19 indexed citations
6.
Savarese, Gianluigi, Erwan Donal, Camilla Hage, et al.. (2016). Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study. International Journal of Cardiology. 226. 65–70. 3 indexed citations
7.
8.
Donal, Erwan, Lars H. Lund, Emmanuel Oger, et al.. (2015). New Echocardiographic Predictors of Clinical Outcome in Patients Presenting with Heart Failure and a Preserved Left Ventricular Ejection Fraction: A Subanalysis of the Ka (Karolinska) Ren (Rennes) Study. European Journal of Heart Failure. 17(7). 680–688. 69 indexed citations
9.
Rocca, Hans‐Peter Brunner‐La, Luc W.M. Eurlings, Mark Richards, et al.. (2015). Which Heart Failure Patients Profit from Natriuretic Peptide Guided Therapy? a Meta-Analysis from Individual Patient Data of Randomized Trials. European Journal of Heart Failure. 17(12). 1252–1261. 67 indexed citations
10.
Desta, Liyew, Tomas Jernberg, Jonas Spaak, Claes Hofman‐Bang, & Hans Persson. (2015). Heart Failure with Normal Ejection Fraction is Uncommon in Acute Myocardial Infarction Settings but Associated with Poor Outcomes: A Study Of 91 360 Patients Admitted with Index Myocardial Infarction between 1998 and 2010. European Journal of Heart Failure. 18(1). 46–53. 18 indexed citations
11.
Lyngå, Patrik, Hans Persson, Ewa Hägglund, et al.. (2012). Weight Monitoring in Patients with Severe Heart Failure (WISH). A Randomized Controlled Trial. European Journal of Heart Failure. 14(4). 438–444. 108 indexed citations
12.
Maggioni, Aldo P., Ulf Dahlström, Gerasimos Filippatos, et al.. (2010). EUR Observational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure. 12(10). 1076–1084. 295 indexed citations
14.
Donal, Erwan, Lars H. Lund, Cecilia Linde, et al.. (2009). Rationale and Design of the Karolinska-Rennes (KaRen) Prospective Study of Dyssynchrony in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 11(2). 198–204. 46 indexed citations
15.
Donal, Erwan, et al.. (2009). What are the True Prognostic Differences Between Heart Failure with Preserved and Reduced Ejection Fraction?. European Journal of Heart Failure. 12(1). 98–98. 1 indexed citations
16.
Landstedt‐Hallin, Lena, Klas Malmberg, A. Melcher, et al.. (2009). A Randomized Trial of the Impact of Strict Glycaemic Control on Myocardial Diastolic Function and Perfusion Reserve: A Report from the DADD (Diabetes Mellitus and Diastolic Dysfunction) Study. European Journal of Heart Failure. 11(1). 39–47. 58 indexed citations
17.
Melcher, A., et al.. (2008). Left aTrial Velocity Vector Imaging for the Detection and Quantification of Left Ventricular Diastolic Function in Type 2 Diabetes. European Journal of Heart Failure. 10(11). 1080–1087. 48 indexed citations
18.
Grewal, Jasmine, Robert S. McKelvie, Eva Lonn, et al.. (2008). BNP and NT-proBNP Predict Echocardiographic Severity of Diastolic Dysfunction. European Journal of Heart Failure. 10(3). 252–259. 101 indexed citations
19.
Bergström, Anders, Bert Andersson, Magnus Edner, et al.. (2004). Effect of Carvedilol on Diastolic Function in Patients with Diastolic Heart Failure and Preserved Systolic Function. Results of the Swedish Doppler-Echocardiographic Study (SWEDIC). European Journal of Heart Failure. 6(4). 453–461. 174 indexed citations
20.
Bergström, Anders, Björn Andersson, Magnus Edner, et al.. (2001). Carvedilol improves diastolic function in patients with diastolic heart failure.. Circulation. 104(17). 3388. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026